1-5 of 5
Stephen Anthony Strickland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/1b Open-Label, Dose Escalation, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Leukemic Activity of the Orally Available CDC-like Kinase Inhibitor, BH-30236, in Adults with R/R AML or HR-MDS

Eytan M. Stein, Leora Boussi, Alice Mims, Justin M. Watts, Gabriel N Mannis, Hongtao Liu, David Sallman, Farhad Ravandi, Gary J. Schiller, Eunice S. Wang, Brian J. Ball, J. Jean Cui, Jihao Zhou, Armin Graber, Zachary Zimmerman, Stephen Anthony Strickland
Journal: Blood
Blood (2024) 144 (Supplement 1): 5998.
https://doi.org/10.1182/blood-2024-204046
Published: 2024
Journal Articles

Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1- m or KMT2A -r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007

Amer M. Zeidan, Eunice S. Wang, Ghayas C. Issa, Harry Erba, Jessica Kaplan Altman, Suresh Kumar Balasubramanian, Stephen Anthony Strickland, Gail J. Roboz, Gary J. Schiller, Christine M. McMahon, Neil D. Palmisiano, Yazan F. Madanat, Marcello Rotta, Kalyan Nadiminti, Helen Wei, Marcie Riches, Daniel Corum, Mollie Leoni, Stephen Dale, Amir T. Fathi
Journal: Blood
Blood (2024) 144 (Supplement 1): 214.
https://doi.org/10.1182/blood-2024-198218
Published: 2024
Journal Articles

Phase 1 Results: First-in-Human Phase 1/2 Study of the Menin-MLL Inhibitor Enzomenib (DSP-5336) in Patients with Relapsed or Refractory Acute Leukemia

Joshua F Zeidner, Junichiro Yuda, Justin M. Watts, Mark J. Levis, Harry P. Erba, Kentaro Fukushima, Takahiro Shima, Neil D. Palmisiano, Eunice S. Wang, Uma Borate, Joseph Brandwein, Cristina Papayannidis, Pau Montesinos, Gina Keiffer, Yasushi Miyazaki, Naoko Hosono, Takayuki Ikezoe, Yoshiaki Ogawa, Timothy S Pardee, Stephen Anthony Strickland, Koichi Onodera, Shang-Ju Wu, Melissa G Ooi, Emmanuel Raffoux, Susana Vives, Alireza Eghtedar, Hongliang Cai, Curtis Allred, Bo Xu, Priya Robson, Akinobu Watanabe, Matthew Hitron, Jatin Shah, Hagop M. Kantarjian, Naval Daver
Journal: Blood
Blood (2024) 144 (Supplement 1): 213.
https://doi.org/10.1182/blood-2024-194827
Published: 2024
Journal Articles

A First-in-Human, Phase 1, Dose Escalation Study of Sgr-2921 As Monotherapy in Subjects with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Courtney D. DiNardo, Stephen Anthony Strickland, Barry Skikne, Amer M. Zeidan, Elie Traer, Hetty E. Carraway, Stanley Frankel, Daniel E Weiss, Jacky H Wang, Steven Pirie-Shepherd, Joseph Piccotti, D. Hamish Wright, Karen Akinsanya
Journal: Blood
Blood (2023) 142 (Supplement 1): 1548.
https://doi.org/10.1182/blood-2023-186036
Published: 2023
Journal Articles

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, In Older Patients with MDS Refractory to Hypomethylating Agents

Guillermo Garcia-Manero, MD, Selina Luger, MD, Parmeswaran Venugopal, MD, Lori Maness, MD, Meir Wetzler, MD, Jessica K Altman, MD, David F. Claxton, MD, Stephen Anthony Strickland, JR, MD, James M. Foran, MD, FRCPC, Stuart L Goldberg, MD, Judy Chiao, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 1857.
https://doi.org/10.1182/blood.V116.21.1857.1857
Published: 2010